drugset / Trial / NCT02462083
Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis
NaSingle-groupOpen-labelTreatment
Summary
The objective of this study is to evaluate the long-term safety of IDP-118 lotion.
Timeline
- Start
- 2015-08-11
- Primary completion
- 2017-01-31
- Completion
- 2017-04-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tazarotene | Small molecule | 0.045 % | Topical |
| Subject | halobetasol propionate | Small molecule | 0.01 % | Topical |